Construction of Stable Reporter Flaviviruses and Their Applications
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Innate Immunity Evasion by Dengue Virus
Viruses2012, 4, 397-413; doi:10.3390/v4030397 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Innate Immunity Evasion by Dengue Virus Juliet Morrison, Sebastian Aguirre and Ana Fernandez-Sesma * Department of Microbiology and the Global Health and Emerging Pathogens Institute (GHEPI), Mount Sinai School of Medicine, New York, NY 10029-6574, USA; E-Mails: [email protected] (J.M.); [email protected] (S.A.) * Author to whom correspondence should be addressed: E-Mail: [email protected]; Tel.: +1-212-241-5182; Fax: +1-212-534-1684. Received: 30 January 2012; in revised version: 14 February 2012 / Accepted: 7 March 2012 / Published: 15 March 2012 Abstract: For viruses to productively infect their hosts, they must evade or inhibit important elements of the innate immune system, namely the type I interferon (IFN) response, which negatively influences the subsequent development of antigen-specific adaptive immunity against those viruses. Dengue virus (DENV) can inhibit both type I IFN production and signaling in susceptible human cells, including dendritic cells (DCs). The NS2B3 protease complex of DENV functions as an antagonist of type I IFN production, and its proteolytic activity is necessary for this function. DENV also encodes proteins that antagonize type I IFN signaling, including NS2A, NS4A, NS4B and NS5 by targeting different components of this signaling pathway, such as STATs. Importantly, the ability of the NS5 protein to bind and degrade STAT2 contributes to the limited host tropism of DENV to humans and non-human primates. In this review, we will evaluate the contribution of innate immunity evasion by DENV to the pathogenesis and host tropism of this virus. -
Dengue Fever and Dengue Hemorrhagic Fever (Dhf)
DENGUE FEVER AND DENGUE HEMORRHAGIC FEVER (DHF) What are DENGUE and DHF? Dengue and DHF are viral diseases transmitted by mosquitoes in tropical and subtropical regions of the world. Cases of dengue and DHF are confirmed every year in travelers returning to the United States after visits to regions such as the South Pacific, Asia, the Caribbean, the Americas and Africa. How is dengue fever spread? Dengue virus is transmitted to people by the bite of an infected mosquito. Dengue cannot be spread directly from person to person. What are the symptoms of dengue fever? The most common symptoms of dengue are high fever for 2–7 days, severe headache, backache, joint pains, nausea and vomiting, eye pain and rash. The rash is frequently not visible in dark-skinned people. Young children typically have a milder illness than older children and adults. Most patients report a non-specific flu-like illness. Many patients infected with dengue will not show any symptoms. DHF is a more severe form of dengue. Initial symptoms are the same as dengue but are followed by bleeding problems such as easy bruising, skin hemorrhages, bleeding from the nose or gums, and possible bleeding of the internal organs. DHF is very rare. How soon after exposure do symptoms appear? Symptoms of dengue can occur from 3-14 days, commonly 4-7 days, after the bite of an infected mosquito. What is the treatment for dengue fever? There is no specific treatment for dengue. Treatment usually involves treating symptoms such as managing fever, general aches and pains. Persons who have traveled to a tropical or sub-tropical region should consult their physician if they develop symptoms. -
Dengue and Yellow Fever
GBL42 11/27/03 4:02 PM Page 262 CHAPTER 42 Dengue and Yellow Fever Dengue, 262 Yellow fever, 265 Further reading, 266 While the most important viral haemorrhagic tor (Aedes aegypti) as well as reinfestation of this fevers numerically (dengue and yellow fever) are insect into Central and South America (it was transmitted exclusively by arthropods, other largely eradicated in the 1960s). Other factors arboviral haemorrhagic fevers (Crimean– include intercontinental transport of car tyres Congo and Rift Valley fevers) can also be trans- containing Aedes albopictus eggs, overcrowding mitted directly by body fluids. A third group of of refugee and urban populations and increasing haemorrhagic fever viruses (Lassa, Ebola, Mar- human travel. In hyperendemic areas of Asia, burg) are only transmitted directly, and are not disease is seen mainly in children. transmitted by arthropods at all. The directly Aedes mosquitoes are ‘peri-domestic’: they transmissible viral haemorrhagic fevers are dis- breed in collections of fresh water around the cussed in Chapter 41. house (e.g. water storage jars).They feed on hu- mans (anthrophilic), mainly by day, and feed re- peatedly on different hosts (enhancing their role Dengue as vectors). Dengue virus is numerically the most important Clinical features arbovirus infecting humans, with an estimated Dengue virus may cause a non-specific febrile 100 million cases per year and 2.5 billion people illness or asymptomatic infection, especially in at risk.There are four serotypes of dengue virus, young children. However, there are two main transmitted by Aedes mosquitoes, and it is un- clinical dengue syndromes: dengue fever (DF) usual among arboviruses in that humans are the and dengue haemorrhagic fever (DHF). -
WO 2010/142017 Al
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 16 December 2010 (16.12.2010) WO 2010/142017 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 48/00 (2006.01) A61P 37/04 (2006.01) kind of national protection available): AE, AG, AL, AM, A61P 31/00 (2006.01) A61K 38/21 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) Number: International Application DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/CA20 10/000844 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 8 June 2010 (08.06.2010) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/185,261 9 June 2009 (09.06.2009) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): DE- ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, FYRUS, INC . -
Florida Arbovirus Surveillance Week 13: March 28-April 3, 2021
Florida Arbovirus Surveillance Week 13: March 28-April 3, 2021 Arbovirus surveillance in Florida includes endemic mosquito-borne viruses such as West Nile virus (WNV), Eastern equine encephalitis virus (EEEV), and St. Louis encephalitis virus (SLEV), as well as exotic viruses such as dengue virus (DENV), chikungunya virus (CHIKV), Zika virus (ZIKV), and California encephalitis group viruses (CEV). Malaria, a parasitic mosquito-borne disease is also included. During the period of March 28- April 3, 2021, the following arboviral activity was recorded in Florida. WNV activity: No human cases of WNV infection were reported this week. No horses with WNV infection were reported this week. No sentinel chickens tested positive for antibodies to WNV this week. In 2021, positive samples from two sentinel chickens has been reported from two counties. SLEV activity: No human cases of SLEV infection were reported this week. No sentinel chickens tested positive for antibodies to SLEV this week. In 2021, no positive samples have been reported. EEEV activity: No human cases of EEEV infection were reported this week. No horses with EEEV infection were reported this week. No sentinel chickens tested positive for antibodies to EEEV this week. In 2021, positive samples from one horse and 14 sentinel chickens have been reported from four counties. International Travel-Associated Dengue Fever Cases: No cases of dengue fever were reported this week in persons that had international travel. In 2021, one travel-associated dengue fever case has been reported. Dengue Fever Cases Acquired in Florida: No cases of locally acquired dengue fever were reported this week. In 2021, no cases of locally acquired dengue fever have been reported. -
Rousettus Aegyptiacus Amy J
Schuh et al. Parasites & Vectors (2016) 9:128 DOI 10.1186/s13071-016-1390-z SHORT REPORT Open Access No evidence for the involvement of the argasid tick Ornithodoros faini in the enzootic maintenance of marburgvirus within Egyptian rousette bats Rousettus aegyptiacus Amy J. Schuh1, Brian R. Amman1, Dmitry A. Apanaskevich2, Tara K. Sealy1, Stuart T. Nichol1 and Jonathan S. Towner1* Abstract Background: The cave-dwelling Egyptian rousette bat (ERB; Rousettus aegyptiacus) was recently identified as a natural reservoir host of marburgviruses. However, the mechanisms of transmission for the enzootic maintenance of marburgviruses within ERBs are unclear. Previous ecological investigations of large ERB colonies inhabiting Python Cave and Kitaka Mine, Uganda revealed that argasid ticks (Ornithodoros faini) are hematophagous ectoparasites of ERBs. Yet, their potential role as transmission vectors for marburgvirus has not been sufficiently assessed. Findings: In the present study, 3,125 O. faini were collected during April 2013 from the rock crevices of Python Cave, Uganda. None of the ticks tested positive for marburgvirus-specific RNA by Q-RT-PCR. The probability of failure to detect marburgvirus at a conservative prevalence of 0.1 % was 0.05. Conclusions: The absence of marburgvirus RNA in O. faini suggests they do not play a significant role in the transmission and enzootic maintenance of marburgvirus within their natural reservoir host. Keywords: Filovirus, Marburgvirus, Marburg virus, Tick, Argasid, Ornithodoros, Egyptian rousette bat, Rousettus aegyptiacus, Transmission, Maintenance Findings IgG antibodies [3, 4] and the isolation of infectious mar- Introduction burgvirus [1–3, 5] from ERBs inhabiting caves associated The genus Marburgvirus (Filoviridae), includes a single with recent human outbreaks. -
Combatting Malaria, Dengue and Zika Using Nuclear Technology by Nicole Jawerth and Elodie Broussard
Infectious Diseases Combatting malaria, dengue and Zika using nuclear technology By Nicole Jawerth and Elodie Broussard A male Aedes species mosquito. iseases such as malaria, dengue and transcription–polymerase chain reaction (Photo: IAEA) Zika, spread by various mosquito (RT–PCR) (see page 8). Experts across the Dspecies, are wreaking havoc on millions of world have been trained and equipped by lives worldwide. To combat these harmful the IAEA to use this technique for detecting, and often life-threatening diseases, experts tracking and studying pathogens such as in many countries are turning to nuclear and viruses. The diagnostic results help health nuclear-derived techniques for both disease care professionals to provide treatment and detection and insect control. enable experts to track the viruses and take action to control their spread. Dengue and Zika When a new outbreak of disease struck in The dengue virus and Zika virus are mainly 2015 and 2016, physicians weren’t sure of spread by Aedes species mosquitoes, which its cause, but RT–PCR helped to determine are most common in tropical regions. In most that the outbreak was the Zika virus and not cases, the dengue virus causes debilitating another virus such as dengue. RT–PCR was flu-like symptoms, but all four strains of the used to detect the virus in infected people virus also have the potential to cause severe, throughout the epidemic, which was declared life-threatening diseases. In the case of the Zika a public health emergency of international virus, many infected people are asymptomatic concern by the World Health Organization or only have mild symptoms; however, the virus (WHO) in January 2016. -
Dengue Fever (Breakbone Fever, Dengue Hemorrhagic Fever)
Division of Disease Control What Do I Need to Know? Dengue Fever (breakbone fever, dengue hemorrhagic fever) What is Dengue Fever? Dengue fever is a serious form of mosquito-borne disease caused one of four closely related viruses called Flaviviruses. They are named DENV 1, DENV 2, DENV 3, or DENV 4. The disease is found in most tropical and subtropical areas (including some islands in the Caribbean, Mexico, most countries of South and Central America, the Pacific, Asia, parts of tropical Africa and Australia). Almost all cases reported in the continental United States are in travelers who have recently returned from countries where the disease circulates. Dengue is endemic to the U.S. territories of Puerto Rico, the Virgin Islands, and Guam and in recent years non-travel related cases have been found in Texas, Florida, and Hawaii. Who is at risk for Dengue Fever? Dengue fever may occur in people of all ages who are exposed to infected mosquitoes. The disease occurs in areas where the mosquitos that carry dengue circulate, usually during the rainy seasons when mosquito populations are at high numbers. What are the symptoms of Dengue Fever? Dengue fever is characterized by the rapid development of fever that may last from two to seven days, intense headache, joint and muscle pain and a rash. The rash develops on the feet or legs three to four days after the beginning of the fever. Some people with dengue develop dengue hemorrhagic fever (DHF). Symptoms of DHF are characteristic of internal bleeding and include: severe abdominal pain, red patches on skin, bleeding from nose or gums, black stools, vomiting blood, drowsiness, cold and clammy skin and difficulty breathing. -
Prevent Dengue & Chikungunya
Prevent Dengue & Chikungunya WHO Myanmar newsletter special, 9 September 2019 What is dengue? Dengue situation in Myanmar Dengue is one of the most common mosquito- Cases and deaths 2015-2019 borne viral infections. The infection is spread from one person to another through the bite of infectious mosquitoes, either Aedes aegypti or Aedes albopictus. There are 4 distinct types of dengue virus, called DEN-1, DEN-2, DEN-3 and DEN-4. Dengue can be mild, as in most cases, or severe, as in few cases. It can cause serious illness and death among children. In Myanmar, July to August is peak season for transmission of dengue - coinciding with monsoon. How every one of us can help prevent dengue source: VBDC, Department of Public Health, Ministry of Health & Sports, 2019 z community awareness for mosquito breeding As shown above, dengue is cyclical in Myanmar, control is key alternating annually, as is the case in many countries. z cover, empty and clean domestic water storage At the same time, the number of dengue cases, and containers -- weekly is best deaths due to denge, over the period 2015 to 2018, z remove from the environment plastic bottles, both show a decreasing trend overall. plastic bags, fruit cans, discarded tyres -- for these are preferred mosquito breeding sites by Examples of how national and local authorities aedes aegypti (depicted) and aedes albopictus contribute z drain water collection points around the house z providing support for dengue management at z seek advice of a health professional if you have health facilities. multiple signs or symptoms of dengue z strengthening online reporting of dengue, How to recognize dengue? what are signs and using electronic based information system. -
Guiding Dengue Vaccine Development Using Knowledge Gained from the Success of the Yellow Fever Vaccine
Cellular & Molecular Immunology (2016) 13, 36–46 ß 2015 CSI and USTC. All rights reserved 1672-7681/15 $32.00 www.nature.com/cmi REVIEW Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine Huabin Liang, Min Lee and Xia Jin Flaviviruses comprise approximately 70 closely related RNA viruses. These include several mosquito-borne pathogens, such as yellow fever virus (YFV), dengue virus (DENV), and Japanese encephalitis virus (JEV), which can cause significant human diseases and thus are of great medical importance. Vaccines against both YFV and JEV have been used successfully in humans for decades; however, the development of a DENV vaccine has encountered considerable obstacles. Here, we review the protective immune responses elicited by the vaccine against YFV to provide some insights into the development of a protective DENV vaccine. Cellular & Molecular Immunology (2016) 13, 36–46; doi:10.1038/cmi.2015.76 Keywords: dengue virus; protective immunity; vaccine; yellow fever INTRODUCTION from a viremic patient and is capable of delivering viruses to its Flaviviruses belong to the family Flaviviridae, which includes offspring, thereby amplifying the number of carriers of infec- mosquito-borne pathogens such as yellow fever virus (YFV), tion.6,7 Because international travel has become more frequent, Japanese encephalitis virus (JEV), dengue virus (DENV), and infected vectors can be transported much more easily from an West Nile virus (WNV). Flaviviruses can cause human diseases endemic region to other areas of the world, rendering vector- and thus are considered medically important. According to borne diseases such as dengue fever a global health problem. -
Transmission of Dengue Virus Without a Mosquito Vector: Nosocomial
BRIEF REPORT Transmission of Dengue Virus had recently returned from Peru; the presumed mechanism of transmission was mucocutaneous exposure that occurred dur- without a Mosquito Vector: ing medical care. We describe both cases of dengue fever and Nosocomial Mucocutaneous review the ways that dengue virus can be transmitted without mosquito vectors. Transmission and Other Routes Case reports. Patient 1, a 48-year-old female traveler, pres- of Transmission ented in November 2002 with a 5-day history of fever, myalgia, Downloaded from https://academic.oup.com/cid/article/39/6/e56/359683 by guest on 30 September 2021 and headache. She had recently returned from Iquitos, Peru Lin H. Chen1,2,3 and Mary E. Wilson1,3 (on a trip that lasted from 1 through 10 November), where 1Harvard Medical School, and 2Travel Medicine Center and 3Division of she worked as a nurse on a medical mission and traveled Infectious Diseases, Mount Auburn Hospital, Cambridge, Massachusetts through the Amazon jungles. She stayed in a hotel that had unscreened, open windows. The patient had received hepatitis A virus, hepatitis B virus, and oral typhoid vaccines prior to We report a case of dengue fever in a Boston-area health travel, and she took mefloquine hydrochloride for malaria pro- care worker with no recent history of travel but with mu- phylaxis. She had received yellow fever vaccine in 1997. cocutaneous exposure to infected blood from a febrile trav- At examination, the patient’s temperature was 37.9ЊC. Ab- eler who had recently returned from Peru. Serologic tests normal findings included marked erythroderma, especially on confirmed acute dengue virus infection in both the traveler the patient’s back, and a maculopapular rash along her hairline. -
The Molecular Characterization and the Generation of a Reverse Genetics System for Kyasanur Forest Disease Virus by Bradley
The Molecular Characterization and the Generation of a Reverse Genetics System for Kyasanur Forest Disease Virus by Bradley William Michael Cook A Thesis submitted to the Faculty of Graduate Studies of The University of Manitoba in partial fulfilment of the requirements of the degree of Master of Science Department of Microbiology University of Manitoba Winnipeg, Manitoba, Canada Copyright © 2010 by Bradley William Michael Cook 1 List of Abbreviations: AHFV - Alkhurma Hemorrhagic Fever Virus Amp – ampicillin APOIV - Apoi Virus ATP – adenosine tri-phosphate BAC – bacterial artificial chromosome BHK – Baby Hamster Kidney BSA – bovine serum albumin C1 – C-terminus fragment 1 C2 – C-terminus fragment 2 C - Capsid protein cDNA – comlementary Deoxyribonucleic acid CL – Containment Level CO2 – carbon dioxide cHP - capsid hairpin CNS - Central Nervous System CPE – cytopathic effect CS - complementary sequences DENV1-4 - Dengue Virus DIC - Disseminated Intravascular Coagulation (DIC) DNA – Deoxyribonucleic acid DTV - Deer Tick Virus 2 E - Envelope protein EDTA - ethylenediaminetetraacetic acid EM - Electron Microscopy EMCV – Encephalomyocarditis Virus ER - endoplasmic reticulum FBS – fetal bovine serum FP - fusion peptide GGEV - Greek Goat Encephalitis Virus GGYV - Gadgets Gully Virus GMP - Guanosine mono-phosphate GTP - Guanosine tri-phosphate HBV- Hepatitis B Virus HDV – Hepatitis Delta Virus HIV - Human Immunodeficiency Virus IFN – interferon IRES – internal ribosome entry sequence JEV - Japanese Encephalitis Virus KADV - Kadam Virus kDa -